ArticleClinical cancer research : an official journal of the American Association for Cancer Research2024

Development of Resistance to Type II JAK2 Inhibitors in MPN Depends on AXL Kinase and Is Targetable.

Tamara Codilupi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.